The treatment of lipodystrophy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/00 (2006.01) A61K 31/223 (2006.01) A61K 31/401 (2006.01) A61K 31/403 (2006.01) A61K 31/417 (2006.01) A61K 31/4178 (2006.01) A61K 31/4184 (2006.01) A61K 31/422 (2006.01) A61K 31/472 (2006.01) A61K 31/519 (2006.01) A61K 31/55 (2006.01) A61K 31/551 (2006.01) A61K 31/554 (2006.01) A61K 31/675 (2006.01) A61P 3/00 (2006.01)

Patent

CA 2456549

An inhibitor of the renin-angiotensin system is useful for the treatment or prevention of the lipodystrophy syndrome, e.g. in AIDS patients also receiving anti-retroviral therapy.

L'invention concerne un inhibiteur du système rénine-angiotensine utilisé pour le traitement ou pour la prévention du syndrome lipodystrophie, par exemple, chez des patients atteints du SIDA également soumis à une thérapie antirétrovirale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The treatment of lipodystrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The treatment of lipodystrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The treatment of lipodystrophy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1572033

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.